Professional Issues >> Total Wellness

Casey DE. Side effect profiles of new antipsychotic agents. J Clin Psychiatry 1996 (suppl 11):40-45

Allison DB, Mentore JL, Heo M, et al. Weight gain associated with conventional and newer antipsychotics. Eur Neuropsychopharmacol 1998;8(suppl 2):S216-217

Sanger TM, Lieberman JA, Tohen M, et al. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry 1999;156:79-87

Misra LK, Erpenbach JE, Hamlyn H, et al. Quetiapine: a new atypical antipsychotic. S D J Med 1998;51:189-193

Keck P Jr, Buffenstein A, Ferguson J, et al. Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-weeek placebo-controlled trial. Psychopharmacology (Berl) 1998;140:173-184

Daniel DG, Zimbroff DL, Potkin SG, et al, for the Ziprasidone Study Group. Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Neuropsychopharmacology (Berl) 1998;140:173-184

Gerlach J. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment. J Clin Psychiatry 1999;60(suppl 23):20-24

Petty RG. Management of chronic Psychotic ambulatory outpatients. J Clin Psychiatry 1998;59(suppl 19):30-35

World Health Organization. Prophylactic use of anticholinergics in patients on long-term neuroleptic treatment. Br J Psychiatry 1990;156:412-414

Miller DD. Review and Management of clozapine side effects. J Clin Psychiatry 2000;61(suppl 8):14-17

Buckley P. New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. J Clin Psychopharmacol 1997;37:363-378

Glazer WM. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality. J Clin Psychiatry 2000;61(suppl 3):16-21

Arvanitis LA, Miller BG, and the Seroquel Trial 13 Study Group. Multiple fixed doses of Seroquel (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. Biol Psychiatry 1997;42:233-246

Garver DL. Review of quetiapine side effects. J Clin Psychiatry 2000;61(suppl 8):31-33

Welch R, Chue P. Antipsychotic agents and QT changes. J Psychiatry Neurosci 2000;25:154-160

Choy AM, Lang CC, Roden DM, et al. Abnormalities of the QT interval in primary disorders of autonomic failure. Am Heart J 1998;136:664-671

Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355:1048-1052

Kang UG, Kwon JS, Ahn YM, et al. Electrocardiographic abnormalities in patients treated with clozapine. J Clin Psychiatry 2000;61:441-446

Olanzapine [package insert]. Indianapolis, IN: Eli Lilly and Company; 2000

Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother 1997;31:867-870

Posey DJ, Walsh KH, Wilson GA, et al. Risperidone in the treatment of two very young children with autism. J Child Adolesc Psychopharmacol 1999;9:273-276

Lewis R, Bagnall A, Leitner M. Sertindole for schizophrenia. Cochrane Database Syst Rev 2000;(2):CD001715

McManus DQ, Arvantis LA, Kowalcik BB for the Seroquel Trial 48 Study Group. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 1999;60:292-298

Husty FM. Acute quetiapine poisoning. J Emerg Med 1999;17:995-997. Correction 2000;18:403

Hamner MB, Arana GW. Hyperprolactinemia in antipsychotic-treated patients: guidelines for avoidance and management. CNS Drugs 1998;10:209-222

Wirshing DA, Spellberg BJ, Erhart SM, et al. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998;44:778-783

Beasley CM Jr, Tollefson G, Tran P, et al. and The Olanzapine HGAD Study Group. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 1996;14:111-123

Kim YK, Kim L, Lee MS. Risperidone and associated amenorrhea: a report of 5 cases. J Clin Psychiatry 1999;60:315-317

Dickson RA, Dalby JT, Williams R, et al. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia[letter]. Am J Psychiatry 1995;152:1102-1103

Aquila R, Emanuel M. Interventions for weight gain in adults treated with novel antipsychotics. Primary Care Companion J Clin Psychiatry 2000;2:20-23

Taylor DM, McAskill R. Atypical antipsychotics and weight gain: a systematic review. Acta Psychiatr Scand 2000;101:416-432

Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight-gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-1696

Beasley CM, Tollefson GD, Tran PV. Safety of olanzapine. J Clin Psychiatry 1997;58(suppl 10):13-17

Mukherjee S, Decina P, Bocola V, et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996;37:68-73

Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. AM J Psychiatry 1999;156(9):1417-1420